Hap Trading, LLC Mannkind Corp Call Options Transaction History

Hap Trading, LLC

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $10,570 - $18,795	3,500 Added 8.95%	42,600 $34,000
Q3 2022 Nov 14, 2022	SELL	$2.99 - $4.35 $24,518 - $35,670	-8,200 Reduced 17.34%	39,100 $5,000
Q2 2022 Aug 12, 2022	BUY	$2.67 - $4.77 $6,675 - $11,924	2,500 Added 5.58%	47,300 $18,000
Q1 2022 May 12, 2022	SELL	$2.62 - $4.45 $262 - $445	-100 Reduced 0.22%	44,800 $13,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $63,180 - $83,772	15,600 Added 53.24%	44,900 $19,000
Q3 2021 Nov 10, 2021	BUY	$3.89 - $5.48 $6,224 - $8,768	1,600 Added 5.78%	29,300 $26,000
Q2 2021 Aug 11, 2021	BUY	$3.61 - $5.45 $19,494 - $29,430	5,400 Added 24.22%	27,700 $36,000
Q1 2021 May 14, 2021	SELL	$3.14 - $6.14 $76,616 - $149,816	-24,400 Reduced 52.25%	22,300 $20,000
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $49,046 - $110,696	27,400 Added 141.97%	46,700 $15,000
Q3 2020 Nov 13, 2020	SELL	$1.56 - $2.08 $53,976 - $71,968	-34,600 Reduced 64.19%	19,300 $6,000
Q2 2020 Aug 10, 2020	BUY	$0.94 - $2.21 $28,294 - $66,521	30,100 Added 126.47%	53,900 $7,000
Q1 2020 May 08, 2020	BUY	$0.84 - $1.76 $4,704 - $9,856	5,600 Added 30.77%	23,800 $3,000
Q4 2019 Feb 11, 2020	BUY	$1.14 - $1.49 $20,748 - $27,118	18,200 New	18,200 $1,000
Q1 2019 May 10, 2019	SELL	$1.14 - $2.25 $16,073 - $31,725	-14,100 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$1.02 - $2.05 $3,672 - $7,379	3,600 Added 34.29%	14,100 $0
Q3 2018 Nov 09, 2018	BUY	$1.01 - $2.19 $10,605 - $22,995	10,500 New	10,500 $2,000

274

172M

1.37M

241K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.06B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.